NSL literature pointer PMID 8907434 L-Carnitine laboratory index [PMID: 8907434] National Science Labs indexing note for PMID 8907434: review the PubMed methods, models, and limitations before citing
Here, we discuss the role of oxidative/nitrative/nitrosative stress in ASD pathogenesis
May 26 Gut Health The GLP-1 Clinical Framework: Integrating Nutrition into Metabolic Care GLP-1 therapies are reshaping metabolic care at unprecedented speed but alongside the headlines, clinicians are left navigating complex questions around long-term outcomes, sustainability, nutrition, and patient dependency
By Patricia Van Arnum, Editorial Director, DCAT, [email protected] Lilly and Novo Nordisk battle in oral obesity drug market The battle in the obesity drug market is heating up as this week (April 1, 2026) Eli Lilly and Company reported that it had received approval from the US Food and Drug Administration (FDA) for its oral obesity drug, Foundayo (orforglipron)
February 2026: Zepbounds sales exceeded expectations by nearly $1 billion in the last quarter of 2025, according to Eli Lillys most recent earnings report
